Zimmer Biomet Holdings Debt to Equity Ratio 2010-2025 | ZBH
Zimmer Biomet Holdings Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2025-03-31 | $9.78B | $12.40B | 0.79 |
2024-12-31 | $8.89B | $12.48B | 0.71 |
2024-09-30 | $9.34B | $12.38B | 0.75 |
2024-06-30 | $8.77B | $12.75B | 0.69 |
2024-03-31 | $8.85B | $12.61B | 0.70 |
2023-12-31 | $9.01B | $12.49B | 0.72 |
2023-09-30 | $8.70B | $12.52B | 0.70 |
2023-06-30 | $8.92B | $12.38B | 0.72 |
2023-03-31 | $9.09B | $12.16B | 0.75 |
2022-12-31 | $9.04B | $12.03B | 0.75 |
2022-09-30 | $9.08B | $12.25B | 0.74 |
2022-06-30 | $9.33B | $12.13B | 0.77 |
2022-03-31 | $9.60B | $12.02B | 0.80 |
2021-12-31 | $10.79B | $12.67B | 0.85 |
2021-09-30 | $11.29B | $12.71B | 0.89 |
2021-06-30 | $11.64B | $12.58B | 0.93 |
2021-03-31 | $11.58B | $12.45B | 0.93 |
2020-12-31 | $12.22B | $12.20B | 1.00 |
2020-09-30 | $12.15B | $11.88B | 1.02 |
2020-06-30 | $12.00B | $11.64B | 1.03 |
2020-03-31 | $13.63B | $11.88B | 1.15 |
2019-12-31 | $12.25B | $12.39B | 0.99 |
2019-09-30 | $12.23B | $12.09B | 1.01 |
2019-06-30 | $12.54B | $11.66B | 1.08 |
2019-03-31 | $12.75B | $11.54B | 1.11 |
2018-12-31 | $12.85B | $11.28B | 1.14 |
2018-09-30 | $13.16B | $12.22B | 1.08 |
2018-06-30 | $13.45B | $12.04B | 1.12 |
2018-03-31 | $15.18B | $12.00B | 1.27 |
2017-12-31 | $14.28B | $11.74B | 1.22 |
2017-09-30 | $15.97B | $10.45B | 1.53 |
2017-06-30 | $16.18B | $10.28B | 1.57 |
2017-03-31 | $17.05B | $9.93B | 1.72 |
2016-12-31 | $17.02B | $9.67B | 1.76 |
2016-09-30 | $17.29B | $9.75B | 1.77 |
2016-06-30 | $16.42B | $9.55B | 1.72 |
2016-03-31 | $16.64B | $9.66B | 1.72 |
2015-12-31 | $17.27B | $9.89B | 1.75 |
2015-09-30 | $16.70B | $9.99B | 1.67 |
2015-06-30 | $17.08B | $10.13B | 1.69 |
2015-03-31 | $10.61B | $6.58B | 1.61 |
2014-12-31 | $3.11B | $6.55B | 0.47 |
2014-09-30 | $3.13B | $6.54B | 0.48 |
2014-06-30 | $3.19B | $6.45B | 0.49 |
2014-03-31 | $3.14B | $6.24B | 0.50 |
2013-12-31 | $3.28B | $6.30B | 0.52 |
2013-09-30 | $3.22B | $6.14B | 0.52 |
2013-06-30 | $3.21B | $5.89B | 0.55 |
2013-03-31 | $3.03B | $5.71B | 0.53 |
2012-12-31 | $3.15B | $5.87B | 0.54 |
2012-09-30 | $2.95B | $5.83B | 0.51 |
2012-06-30 | $2.90B | $5.71B | 0.51 |
2012-03-31 | $2.94B | $5.66B | 0.52 |
2011-12-31 | $3.00B | $5.52B | 0.54 |
2011-09-30 | $2.59B | $5.61B | 0.46 |
2011-06-30 | $2.23B | $6.02B | 0.37 |
2011-03-31 | $2.25B | $5.86B | 0.38 |
2010-12-31 | $2.23B | $5.77B | 0.39 |
2010-09-30 | $2.18B | $5.82B | 0.38 |
2010-06-30 | $2.09B | $5.74B | 0.37 |
2010-03-31 | $2.11B | $5.71B | 0.37 |
2009-12-31 | $2.15B | $5.64B | 0.38 |
2009-09-30 | $1.67B | $5.98B | 0.28 |
2009-06-30 | $1.66B | $5.81B | 0.29 |
2009-03-31 | $1.68B | $5.56B | 0.30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $18.060B | $7.679B |
Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
Boston Scientific (BSX) | United States | $147.560B | 37.59 |
Stryker (SYK) | United States | $144.011B | 30.10 |
EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
Medtronic (MDT) | Ireland | $111.928B | 15.99 |
Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
ResMed (RMD) | United States | $36.560B | 27.72 |
Agilent Technologies (A) | United States | $33.258B | 22.04 |
GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
Terumo (TRUMY) | Japan | $26.680B | 34.37 |
Insulet (PODD) | United States | $21.438B | 84.69 |
Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
Baxter (BAX) | United States | $15.713B | 11.81 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
Demant (WILYY) | Denmark | $9.377B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.94 |
Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.367B | 15.31 |
ICU Medical (ICUI) | United States | $3.250B | 24.18 |
Envista Holdings (NVST) | United States | $3.127B | 26.73 |
GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
AtriCure (ATRC) | United States | $1.565B | 0.00 |
Acuren (TIC) | United States | $1.357B | 0.00 |
Neogen (NEOG) | United States | $1.200B | 15.67 |
AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
InMode (INMD) | Israel | $0.844B | 8.55 |
Evolus (EOLS) | United States | $0.640B | 0.00 |
CeriBell (CBLL) | United States | $0.624B | 0.00 |
Owens & Minor (OMI) | United States | $0.602B | 5.08 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
Valneva SE (VALN) | France | $0.510B | 0.00 |
Surmodics (SRDX) | United States | $0.417B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
SNDL (SNDL) | Canada | $0.339B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
ZimVie (ZIMV) | United States | $0.253B | 11.63 |
Cerus (CERS) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
Quanterix (QTRX) | United States | $0.235B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.207B | 6.12 |
Brainsway (BWAY) | Israel | $0.206B | 55.30 |
Omeros (OMER) | United States | $0.199B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Organigram Global (OGI) | Canada | $0.187B | 0.00 |
High Tide (HITI) | Canada | $0.185B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
Exagen (XGN) | United States | $0.152B | 0.00 |
Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
Jin Medical (ZJYL) | China | $0.107B | 0.00 |
MacroGenics (MGNX) | United States | $0.096B | 0.00 |
Fonar (FONR) | United States | $0.090B | 11.37 |
Veru (VERU) | United States | $0.090B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Agape ATP (ATPC) | $0.084B | 0.00 | |
TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Apyx Medical (APYX) | United States | $0.066B | 0.00 |
Zynex (ZYXI) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 48.64 |
United-Guardian (UG) | United States | $0.037B | 13.19 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
Safety Shot (SHOT) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
INLIF (INLF) | $0.012B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Senestech (SNES) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |